These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 33545413)
1. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts. Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413 [TBL] [Abstract][Full Text] [Related]
2. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response. Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898 [TBL] [Abstract][Full Text] [Related]
3. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study. Muteshi C; Child T; Ohuma E; Fatum M Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359 [TBL] [Abstract][Full Text] [Related]
4. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation in the luteal phase: systematic review and meta-analysis. Boots CE; Meister M; Cooper AR; Hardi A; Jungheim ES J Assist Reprod Genet; 2016 Aug; 33(8):971-80. PubMed ID: 27146151 [TBL] [Abstract][Full Text] [Related]
6. Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis. Sönmezer M; Şükür YE; Ateş C; Saçıntı KG; Sönmezer M; Aslan B; Atabekoğlu CS; Özmen B; Oktay KH Reprod Biomed Online; 2023 Dec; 47(6):103337. PubMed ID: 37857156 [TBL] [Abstract][Full Text] [Related]
7. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature. Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072 [TBL] [Abstract][Full Text] [Related]
9. Fertility preservation for women with breast cancer before chemotherapy: a systematic review and meta-analysis. Chen CN; Chang LT; Chen CH; Tam KW Reprod Biomed Online; 2022 Feb; 44(2):357-369. PubMed ID: 34656436 [TBL] [Abstract][Full Text] [Related]
11. The impact of malignancy on response to ovarian stimulation for fertility preservation: a meta-analysis. Turan V; Quinn MM; Dayioglu N; Rosen MP; Oktay K Fertil Steril; 2018 Dec; 110(7):1347-1355. PubMed ID: 30503134 [TBL] [Abstract][Full Text] [Related]
12. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response. Alvarez RM; Ramanathan P Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of random-start controlled ovarian stimulation in cancer patients. Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940 [TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356 [TBL] [Abstract][Full Text] [Related]
17. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients. Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119 [TBL] [Abstract][Full Text] [Related]
18. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation. İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878 [TBL] [Abstract][Full Text] [Related]
20. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients. Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]